+1 (619) 956-9114 info@myicfos.com
Follow us

Connect live...

Select the exhibitor's booth below and get connected live.

Click on "Edit" in the right panel to replace this with your own HTML code
About Addimmune

Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
Available from 12:00 PM - 4:00 PM (US/Pacific)
+1 301-337-2108

Addimmune is a Rockville, Maryland-based, clinical-stage cell and gene therapy company with a line of sight on a functional HIV cure.  We have completed a successful FDA-approved Phase I human clinical trial with no serious adverse events and have shown blood markers of efficacy in all seven treated trial participants.  An IRB-approved treatment interruption protocol demonstrated the reconstitution of the immune systems of the six who consented to participate.  A $50M capital raise is being undertaken in conjunction with 10X Capital, our Wall Street partners with whom we plan a public transaction via de-SPAC in Q1 of next year, to fund our next phase human clinical trial also to begin in Q1 of 2024.